Clinical Trial Update: Chiron Corp HCV E1/E2 Vaccine [Phase 1]

View source ↗

Summary

Phase 1 study of Chiron's Hepatitis C E1/E2 vaccine sponsored by NIAID has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• HCV E1/E2 vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED